Skip to main content

Larry Marnett

COX-2 ‘conjugate’ may slow growth of some tumors: study

Jan. 19, 2017—More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.

Read more


Basic science, extraordinary impact

Oct. 6, 2016—The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.

Read more


Initiative set to sharpen VUMC’s strategic focus

Jul. 14, 2016—With the transition of Vanderbilt University Medical Center (VUMC) into a new financial and legal entity now complete, Medical Center leaders view this period as an opportunity to sharpen the organization’s strategic focus.

Read more


Influx of major NIH grants fuels growth of research enterprise

Jul. 14, 2016—During the past two weeks, researchers at Vanderbilt University and Vanderbilt University Medical Center (VUMC) have brought in a number of new research grants from the National Institutes of Health (NIH) that together achieve $137 million in new funding. The funding is a trans-institutional accomplishment of the Schools of Engineering and Medicine and the College of Arts and Science.

Read more


13 cross-college collaborative projects win TIPs funding

Jun. 2, 2016—Thirteen interdisciplinary projects, ranging from cellular processes and smart cities to global health care issues, have been selected as the 2016 awardees of the Trans-Institutional Program (TIPs) initiative.

Read more


VIEW MORE EVENTS >